• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prediction of long-term survival rates in patients undergoing curative resection for solitary hepatocellular carcinoma.接受根治性切除的孤立性肝细胞癌患者长期生存率的预测
Oncol Lett. 2018 Feb;15(2):2574-2582. doi: 10.3892/ol.2017.7612. Epub 2017 Dec 13.
2
Shanghai Score: A Prognostic and Adjuvant Treatment-evaluating System Constructed for Chinese Patients with Hepatocellular Carcinoma after Curative Resection.上海评分:为中国肝癌根治性切除术后患者构建的预后和辅助治疗评估系统。
Chin Med J (Engl). 2017 Nov 20;130(22):2650-2660. doi: 10.4103/0366-6999.218019.
3
Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization.炎症评分可预测经动脉化疗栓塞术后乙型肝炎病毒相关肝细胞癌患者的生存情况。
World J Gastroenterol. 2015 May 14;21(18):5582-90. doi: 10.3748/wjg.v21.i18.5582.
4
Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy.淋巴细胞与单核细胞比值及预后营养指数可预测乙型肝炎病毒相关性肝细胞癌患者根治性肝切除术后的生存结局。
J Surg Oncol. 2016 Aug;114(2):202-10. doi: 10.1002/jso.24297. Epub 2016 May 20.
5
Modified CLIP score with the albumin-bilirubin grade retains prognostic value in HBV-related hepatocellular carcinoma patients treated with trans-catheter arterial chemoembolization therapy.结合白蛋白-胆红素分级的改良CLIP评分在接受经动脉化疗栓塞治疗的HBV相关肝细胞癌患者中保留了预后价值。
J Cancer. 2018 Jun 14;9(13):2380-2388. doi: 10.7150/jca.22925. eCollection 2018.
6
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].[一种肝切除术后肝细胞癌的新预后评分系统]
Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005.
7
Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.肝癌患者肝切除术后发生腹腔内感染的肿瘤学预后较差。
World J Gastroenterol. 2015 May 14;21(18):5598-606. doi: 10.3748/wjg.v21.i18.5598.
8
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.甲胎蛋白在代偿性肝硬化监测中发现的小肝细胞癌中无预后作用。
Hepatology. 2012 Oct;56(4):1371-9. doi: 10.1002/hep.25814.
9
Prognostic nutritional index is superior as a predictor of prognosis among various inflammation-based prognostic scores in patients with hepatocellular carcinoma after curative resection.在根治性切除术后的肝细胞癌患者中,预后营养指数作为一种预后预测指标,在各种基于炎症的预后评分中表现更优。
Hepatol Res. 2020 Jan;50(1):101-109. doi: 10.1111/hepr.13431. Epub 2019 Nov 14.
10
A novel prognostic score model based on combining systemic and hepatic inflammation markers in the prognosis of HBV-associated hepatocellular carcinoma patients.一种基于联合全身和肝脏炎症标志物的新型预后评分模型在乙型肝炎病毒相关性肝细胞癌患者预后中的应用。
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):2246-2255. doi: 10.1080/21691401.2019.1573174.

引用本文的文献

1
Prognostic value of neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma receiving curative therapies: a systematic review and meta-analysis.接受根治性治疗的肝细胞癌患者中性粒细胞与淋巴细胞比值的预后价值:一项系统评价和荟萃分析
BMC Cancer. 2025 Mar 29;25(1):571. doi: 10.1186/s12885-025-13972-w.
2
The proliferation of atypical hepatocytes and CDT1 expression in noncancerous tissue are associated with the postoperative recurrence of hepatocellular carcinoma.非癌组织中不典型肝细胞的增生和 CDT1 的表达与肝细胞癌的术后复发相关。
Sci Rep. 2022 Nov 28;12(1):20508. doi: 10.1038/s41598-022-25201-6.
3
Neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers to predict relapse and survival in posthepatectomy HBV-related hepatocellular carcinoma: a meta-analysis and preliminary immune perspective.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值作为预测肝切除术后HBV相关肝细胞癌复发和生存的生物标志物:一项荟萃分析及初步免疫视角
Transl Cancer Res. 2021 Mar;10(3):1261-1272. doi: 10.21037/tcr-20-3125.
4
Prognostic Nomograms for Patients with Hepatocellular Carcinoma After Curative Hepatectomy, with a Focus on Recurrence Timing and Post-Recurrence Management.根治性肝切除术后肝细胞癌患者的预后列线图,重点关注复发时间和复发后管理
J Hepatocell Carcinoma. 2020 Oct 27;7:233-256. doi: 10.2147/JHC.S271498. eCollection 2020.
5
Texture analysis on gadoxetic acid enhanced-MRI for predicting Ki-67 status in hepatocellular carcinoma: A prospective study.钆塞酸增强磁共振成像纹理分析预测肝细胞癌Ki-67状态的前瞻性研究
Chin J Cancer Res. 2019 Oct;31(5):806-817. doi: 10.21147/j.issn.1000-9604.2019.05.10.
6
Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio.基础肝脏疾病和晚期肝癌与中性粒细胞-淋巴细胞比值升高有关。
Clin Mol Hepatol. 2019 Sep;25(3):305-316. doi: 10.3350/cmh.2019.0004. Epub 2019 Apr 19.
7
PASNet: pathway-associated sparse deep neural network for prognosis prediction from high-throughput data.PASNet:基于通路关联稀疏深度神经网络的高通量数据预后预测方法。
BMC Bioinformatics. 2018 Dec 17;19(1):510. doi: 10.1186/s12859-018-2500-z.
8
Effect of KI-67 positive cellular index on prognosis after hepatectomy in Barcelona Clinic Liver Cancer stage A and B hepatocellular carcinoma with microvascular invasion.KI-67阳性细胞指数对巴塞罗那临床肝癌分期A和B期伴微血管侵犯的肝细胞癌肝切除术后预后的影响。
Onco Targets Ther. 2018 Aug 10;11:4747-4754. doi: 10.2147/OTT.S165244. eCollection 2018.

本文引用的文献

1
Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio.埃德蒙森-施泰纳分级:无微血管侵犯的肝细胞癌复发和生存的关键预测指标。
Pathol Res Pract. 2017 Jul;213(7):824-830. doi: 10.1016/j.prp.2017.03.002. Epub 2017 Mar 8.
2
Body mass index and cholesterol level predict surgical outcome in patients with hepatocellular carcinoma in Taiwan - a cohort study.身体质量指数和胆固醇水平可预测台湾肝细胞癌患者的手术结果——一项队列研究。
Oncotarget. 2016 Apr 19;7(16):22948-59. doi: 10.18632/oncotarget.8312.
3
Neutrophil to lymphocyte ratio as an indicator of the malignant behaviour of hepatocellular carcinoma.中性粒细胞与淋巴细胞比值作为肝细胞癌恶性行为的指标。
Br J Surg. 2016 Jun;103(7):891-8. doi: 10.1002/bjs.10123. Epub 2016 Mar 23.
4
C-Reactive Protein as a Prognostic Marker in Patients with Hepatocellular Carcinoma.C反应蛋白作为肝细胞癌患者的预后标志物
Hepatogastroenterology. 2015 Jun;62(140):966-70.
5
A Novel and Validated Inflammation-Based Score (IBS) Predicts Survival in Patients With Hepatocellular Carcinoma Following Curative Surgical Resection: A STROBE-Compliant Article.一种新型且经过验证的基于炎症的评分(IBS)可预测肝细胞癌患者根治性手术切除后的生存率:一篇符合STROBE标准的文章。
Medicine (Baltimore). 2016 Feb;95(7):e2784. doi: 10.1097/MD.0000000000002784.
6
Human topoisomerase II alpha as a prognostic biomarker in cancer chemotherapy.人拓扑异构酶IIα作为癌症化疗中的一种预后生物标志物。
Tumour Biol. 2016 Jan;37(1):47-55. doi: 10.1007/s13277-015-4270-9. Epub 2015 Oct 20.
7
Prognostic Nomograms for Pre- and Postoperative Predictions of Long-Term Survival for Patients Who Underwent Liver Resection for Huge Hepatocellular Carcinoma.接受巨大肝细胞癌肝切除术患者长期生存术前和术后预测的预后列线图
J Am Coll Surg. 2015 Nov;221(5):962-974.e4. doi: 10.1016/j.jamcollsurg.2015.08.003. Epub 2015 Aug 10.
8
Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis.肝细胞癌患者中高Ki-67标记指数的临床病理及预后意义:一项荟萃分析
Int J Clin Exp Med. 2015 Jul 15;8(7):10235-47. eCollection 2015.
9
Nomograms for Pre- and Postoperative Prediction of Long-term Survival for Patients Who Underwent Hepatectomy for Multiple Hepatocellular Carcinomas.接受多灶性肝细胞癌肝切除术患者长期生存的术前和术后预测列线图
Ann Surg. 2016 Apr;263(4):778-86. doi: 10.1097/SLA.0000000000001339.
10
TOP2A amplification and overexpression in hepatocellular carcinoma tissues.TOP2A在肝细胞癌组织中的扩增及过表达
Biomed Res Int. 2015;2015:381602. doi: 10.1155/2015/381602. Epub 2015 Jan 28.

接受根治性切除的孤立性肝细胞癌患者长期生存率的预测

Prediction of long-term survival rates in patients undergoing curative resection for solitary hepatocellular carcinoma.

作者信息

Cao Yi, Jiang Zhelong, Wang Shaohu, Zhang Haoyang, Jiang Yi, Lv Lizhi

机构信息

Department of Hepatobiliary Surgery, Fuzhou General Hospital (Dongfang Hospital), Fuzhou, Fujian 350025, P.R. China.

Department of Hepatobiliary Surgery Fuzong Clinical College of Fujian Medical University, Fuzhou, Fujian 350004, P.R. China.

出版信息

Oncol Lett. 2018 Feb;15(2):2574-2582. doi: 10.3892/ol.2017.7612. Epub 2017 Dec 13.

DOI:10.3892/ol.2017.7612
PMID:29434976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5777370/
Abstract

The present study developed a novel laboratory-based algorithm to predict long-term survival rates in patients undergoing curative resection for solitary hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). The present study included 426 patients with solitary HBV-related HCC who underwent surgery for primary tumors at a single center between 2003 and 2012. Demographic characteristics, laboratory analysis, clinical pathology and immunohistochemistry of topoisomerase II-a and Ki67 were analyzed. A simple prognostic risk calculator was developed using regression coefficients from multivariate models. A prognostic risk calculator incorporating tumor encapsulation, neutrophil-to-lymphocyte ratio, vascular invasion, α-fetoprotein level, Edmondson-Steiner classification, Topo II-α, prognostic nutritional index and Child-Pugh grade was constructed. The prognostic model demonstrated good discrimination with a C-index prior to adjustment of 0.81 (95% confidence interval: 0.78-0.84) and a bootstrap-corrected C-index of 0.81. Kaplan-Meier curves demonstrated that the probabilities of overall survival rates in the low-risk group were increased compared with those in the high-risk group. The areas under the receiver operating characteristic curve using the method were greater compared with those under the 7th Tumor-Node-Metastasis system and Cancer of the Liver Italian Program scoring system [0.83 vs. 0.62 and 0.77 (P<0.001), respectively]. The simple prognostic model of the present study accurately predicted survival rates in patients. Such a prognostic risk calculator for staging patients undergoing curative resection for solitary HBV-related HCC facilitates clinical surveillance and therapy.

摘要

本研究开发了一种基于实验室的新型算法,以预测接受根治性切除的孤立性乙型肝炎病毒(HBV)相关肝细胞癌(HCC)患者的长期生存率。本研究纳入了426例2003年至2012年间在单一中心接受原发性肿瘤手术的孤立性HBV相关HCC患者。分析了人口统计学特征、实验室分析、临床病理以及拓扑异构酶II-α和Ki67的免疫组化情况。利用多变量模型的回归系数开发了一个简单的预后风险计算器。构建了一个包含肿瘤包膜、中性粒细胞与淋巴细胞比值、血管侵犯、甲胎蛋白水平、Edmondson-Steiner分级、拓扑异构酶II-α、预后营养指数和Child-Pugh分级的预后风险计算器。该预后模型在调整前的C指数为0.81(95%置信区间:0.78 - 0.84),经自抽样校正后的C指数为0.81,显示出良好的区分度。Kaplan-Meier曲线表明,低风险组的总生存率概率高于高风险组。使用该方法得到的受试者工作特征曲线下面积大于第七版肿瘤-淋巴结-转移系统和意大利肝癌项目评分系统下的面积[分别为0.83对0.62和0.77(P<0.001)]。本研究的简单预后模型准确预测了患者的生存率。这种用于对接受根治性切除的孤立性HBV相关HCC患者进行分期的预后风险计算器有助于临床监测和治疗。